Stay updated on Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.

Latest updates to the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.7%
- Check20 days agoChange DetectedThe page has been updated to version 2.16.3, but a significant resource link to the H. Lee Moffitt Cancer Center and its clinical trials has been removed.SummaryDifference0.6%
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check35 days agoChange DetectedThe ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation.SummaryDifference1%
- Check42 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check56 days agoChange DetectedThe webpage has updated the results reporting dates, with new dates for submissions and postings, and has removed outdated information regarding previous results. Additionally, there are changes in the numerical data related to the study.SummaryDifference2%
Stay in the know with updates to Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.